New PET tracer may identify diverse invasive mold infections behind life-threatening illnesses in cancer and transplant patients: Study Dr. Kamal Kant Kohli24 Jun 2025 8:45 PM ISTA novel PET radiotracer can accurately detect a wide range of mold species that are linked to dangerous infections, according to new research...
Biocon, NCSM partner to launch oncology support program Ruchika Sharma24 Jun 2025 10:15 AM ISTThis collaboration combines Biocon's expertise in biosimilars with NCSM's community outreach to enhance cancer care accessibility, affordability in...
Bevacizumab and erlotinib combo effective in papillary renal-cell carcinoma patients: NEJM Jacinthlyn Sylvia23 Jun 2025 10:00 PM ISTA new study published in The New England Journal of Medicine showed that bevacizumab and erlotinib together demonstrated efficacy in individuals with...
Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag International Ruchika Sharma21 Jun 2025 3:56 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
Vitamin D increases likelihood that breast cancer will disappear with chemotherapy: Study Dr. Kamal Kant Kohli20 Jun 2025 9:15 PM ISTA study conducted at the Botucatu School of Medicine at Sao Paulo State University (FMB-UNESP) in Brazil has shown that low-dose vitamin D...
For patients with multiple cancers, colorectal cancer diagnosis could be lifesaving-or life-threatening: Study Dr. Kamal Kant Kohli19 Jun 2025 9:15 PM ISTA new study using one of the world's largest cancer registries shows that patient outcomes can be significantly impacted depending on when colorectal...
No increased risk of gynecological cancer with testosterone use after five years: Study Dr. Kamal Kant Kohli19 Jun 2025 8:45 PM ISTTransmasculine and gender-diverse individuals who use testosterone are not at increased risk of gynecological cancer in the first years of hormone...
Medical Bulletin 19/June/2025 Dr. Bhumika Maikhuri19 Jun 2025 3:00 PM ISTHere are the top medical bulletins for the day:47% of India’s Low Birthweight Babies Born in these Four States: BMJ Study FindsDespite significant...
Phase 3 trial initiated for Ifinatamab Deruxtecan in Pretreated Metastatic Castration-Resistant Prostate Cancer: Merck, Daiichi Sankyo Ruchika Sharma19 Jun 2025 10:00 AM ISTBasking Ridge: Merck and Daiichi Sankyo have announced that the first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating...
Survey Reveals Only 13 Percent Know Testicular Cancer Hits Men Under 40 Dr. Bhumika Maikhuri19 Jun 2025 8:15 AM ISTA new national survey commissioned by The Ohio State University Comprehensive Cancer Center reveals significant gaps in public awareness around...
UC Davis clinical trial shows biomarkers hold clue in treating aggressive prostate cancer Dr. Kamal Kant Kohli17 Jun 2025 8:30 PM ISTMany men with aggressive prostate cancer can experience a high rate of recurrence despite treatment. A new Phase 2 clinical trial at UC Davis...
Medical Bulletin 17/June/2025 Dr. Bhumika Maikhuri17 Jun 2025 3:00 PM ISTHere are the top medical bulletins for the day:Smarter, Cheaper, Faster AI Tool for Cancer Monitoring: Study FindsA team of scientists from the A*STAR...
